The pathological features include a decrease in antral follicle count (AFC) and anti-Mullerian hormone (AMH) levels within six months postoperatively, which can also be evidenced by various menopausal symptoms, bone loss, and increased risk of hypertension (41–43). This evidence concerns the gene AMH and Hypertension.